FDA Inspection 1053319 — Institute For Reproductive Health
The FDA completed an inspection of Institute For Reproductive Health on May 23, 2018 in Cincinnati, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 23, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Cincinnati, OH (United States)